Gaurav Goparaju
Stock Analyst at Berenberg
(0.19)
# 4,088
Out of 4,784 analysts
7
Total ratings
14.29%
Success rate
-13.28%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Gaurav Goparaju
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| TWST Twist Bioscience | Initiates: Buy | $27 | $40.36 | -33.10% | 1 | Sep 27, 2023 | |
| DNA Ginkgo Bioworks Holdings | Initiates: Buy | $240 | $6.12 | +3,821.57% | 1 | Nov 29, 2022 | |
| ME 23andMe Holding Co. | Initiates: Buy | $140 | $0.61 | +22,990.88% | 1 | Nov 29, 2022 | |
| CERT Certara | Initiates: Buy | $23 | $9.91 | +132.09% | 1 | Sep 8, 2022 | |
| ABSI Absci | Initiates: Buy | $28 | $2.70 | +937.04% | 1 | Feb 1, 2022 | |
| RLAY Relay Therapeutics | Initiates: Buy | $45 | $2.72 | +1,554.41% | 1 | Feb 1, 2022 | |
| SDGR Schrödinger | Initiates: Buy | $91 | $19.96 | +355.91% | 1 | Oct 13, 2021 |
Twist Bioscience
Sep 27, 2023
Initiates: Buy
Price Target: $27
Current: $40.36
Upside: -33.10%
Ginkgo Bioworks Holdings
Nov 29, 2022
Initiates: Buy
Price Target: $240
Current: $6.12
Upside: +3,821.57%
23andMe Holding Co.
Nov 29, 2022
Initiates: Buy
Price Target: $140
Current: $0.61
Upside: +22,990.88%
Certara
Sep 8, 2022
Initiates: Buy
Price Target: $23
Current: $9.91
Upside: +132.09%
Absci
Feb 1, 2022
Initiates: Buy
Price Target: $28
Current: $2.70
Upside: +937.04%
Relay Therapeutics
Feb 1, 2022
Initiates: Buy
Price Target: $45
Current: $2.72
Upside: +1,554.41%
Schrödinger
Oct 13, 2021
Initiates: Buy
Price Target: $91
Current: $19.96
Upside: +355.91%